论文部分内容阅读
目的:探讨临床对高危因素中期妊娠患者运用米非司酮配合利凡诺处理的可行性.方法:将近年到我院终止妊娠的56例高危因素中期妊娠患者纳入研究,通过随机对照法等分成两组,对照组28例选择单纯利凡诺处理,观察组28例选择米非司酮配合利凡诺处理,研究两组的临床处理结局.结果:观察组处理后的引产成功率相比对照组明显更高,宫缩起始时间、产程时间明显更短,软产道裂伤发生率明显更低,差异有统计学意义(P<0.05).结论:对高危因素中期妊娠患者运用米非司酮配合利凡诺处理,引产效果理想、安全,更适合加强推广.
Objective: To explore the clinical feasibility of using mifepristone combined with rivanol in the treatment of mid-term pregnancy with high-risk factors.Methods: Fifty-six middle-term pregnant women at risk of termination of pregnancy in our hospital in recent years were enrolled in the study and randomly divided into three groups according to randomized control 28 patients in the two groups and control group were treated with rivanopile alone, while 28 patients in the observation group were treated with mifepristone plus rivanol.Results: The success rate of induction of labor after observation group was higher than that of control group Group was significantly higher, the onset time of contractions was significantly shorter, the incidence of soft birth canal laceration was significantly lower, the difference was statistically significant (P <0.05) .Conclusion: The risk factors of midterm pregnancy in patients with mifeprist Ketone with rivano treatment, induction of labor is ideal, safe, more suitable to strengthen the promotion.